Cefditoren Pivoxil – Oral products
Additional FDA-identified interpretive criteria
| Minimum Inhibitory Concentrations (mcg/mL) |
Disk Diffusion (zone diameter in mm) |
|||||
|---|---|---|---|---|---|---|
| Pathogen | S | I | R | S | I | R |
| Streptococcus pneumoniae | ≤0.125 | 0.25 | >0.50 | - | - | - |
| Haemophilus influenzae and parainfluenzae |
≤0.125 | 0.25 | >0.50 | - | - | - |
| Streptococcus spp β- Hemolytic Group |
≤0.125 | - | - | - | - | - |
S = Susceptible; I = Intermediate; R = Resistant